[18F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors

被引:2
作者
Lee, Koeun [1 ,2 ]
Kim, Yong-il [2 ]
Oh, Jungsu S. [2 ]
Seo, Seung Yeon [2 ]
Yun, Jae Kwang [3 ]
Lee, Geun Dong [3 ]
Choi, Sehoon [3 ]
Kim, Hyeong Ryul [3 ]
Kim, Yong-Hee [3 ]
Kim, Dong Kwan [3 ]
Park, Seung-Il [3 ]
Ryu, Jin-Sook [2 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Nucl Med, Sch Med, Seoul, South Korea
[2] Univ Ulsan, Dept Nucl Med, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Dept Thorac & Cardiovasc Surg, Asan Med Ctr, Coll Med, Seoul, South Korea
关键词
THYMIC EPITHELIAL TUMORS; F-18-FDG PET/CT; PROGNOSTIC VALUE; HETEROGENEITY; MALIGNANCY; SURVIVAL; MASS;
D O I
10.1038/s41598-023-44913-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primary mediastinal germ cell tumor (MGCT) is an uncommon tumor. Although it has histology similar to that of gonadal germ cell tumor (GCT), the prognosis for MGCT is generally worse than that for gonadal GCT. We performed visual assessment and quantitative analysis of [F-18]fluorodeoxyglucose positron emission tomography/computed tomography ([F-18]FDG PET/CT) for MGCTs. A total of 35 MGCT patients (age=33.1 +/- 16.8 years, F:M=16:19) who underwent preoperative PET/CT were retrospectively reviewed. The pathologic diagnosis of MGCTs identified 24 mature teratomas, 4 seminomas, 5 yolk sac tumors, and 2 mixed germ cell tumors. Visual assessment was performed by categorizing the uptake intensity, distribution, and contour of primary MGCTs. Quantitative parameters including the maximum standardized uptake value (SUVmax), tumor-to-background ratio (TBR), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and maximum diameter were compared between benign and malignant MGCTs. On visual assessment, the uptake intensity was the only significant parameter for differentiating between benign and malignant MGCTs (p=0.040). In quantitative analysis, the SUVmax (p<0.001), TBR (p<0.001), MTV (p=0.033), and TLG (p<0.001) showed significantly higher values for malignant MGCTs compared with benign MGCTs. In receiver operating characteristic (ROC) curve analysis of these quantitative parameters, the SUVmax had the highest area under the curve (AUC) (AUC=0.947, p<0.001). Furthermore, the SUVmax could differentiate between seminomas and nonseminomatous germ cell tumors (p=0.042) and reflect serum alpha fetoprotein (AFP) levels (p=0.012). The visual uptake intensity and SUVmax on [F-18]FDG PET/CT showed discriminative ability for benign and malignant MGCTs. Moreover, the SUVmax may associate with AFP levels.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma [J].
Alongi, Pierpaolo ;
Evangelista, Laura ;
Caobelli, Federico ;
Spallino, Marianna ;
Gianolli, Luigi ;
Midiri, Massimo ;
Picchio, Maria .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) :85-94
[2]   18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters [J].
Aydos, Uguray ;
Tahtaci, Gozde ;
Ozgur Akdemir, Umit ;
Ozet, Ahmet .
NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (11) :1199-1209
[3]   Solid Tumors of the Mediastinum in Adults [J].
Azizad, Shameem ;
Sannananja, Bhagya ;
Restrepo, Carlos S. .
SEMINARS IN ULTRASOUND CT AND MRI, 2016, 37 (03) :196-211
[4]   Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis [J].
Bokemeyer, C ;
Nichols, CR ;
Droz, JP ;
Schmoll, HJ ;
Horwich, A ;
Gerl, A ;
Fossa, SD ;
Beyer, J ;
Pont, J ;
Kanz, L ;
Einhorn, L ;
Hartmann, JT .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1864-1873
[5]   Approaching the Patient with an Anterior Mediastinal Mass: A Guide for Clinicians [J].
Carter, Brett W. ;
Marom, Edith M. ;
Detterbeck, Frank C. .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) :S102-S109
[6]   FDG-PET in the management of germ cell tumor [J].
De Giorgi, Ugo ;
Pupi, A. ;
Fiorentini, G. ;
Rosti, G. ;
Marangolo, M. .
ANNALS OF ONCOLOGY, 2005, 16 :90-94
[7]   [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial [J].
de Wit, M. ;
Brenner, W. ;
Hartmann, M. ;
Kotzerke, J. ;
Hellwig, D. ;
Lehmann, J. ;
Franzius, C. ;
Kliesch, S. ;
Schlemmer, M. ;
Tatsch, K. ;
Heicappell, R. ;
Geworski, L. ;
Amthauer, H. ;
Dohmen, B. M. ;
Schirrmeister, H. ;
Cremerius, U. ;
Bokemeyer, C. ;
Bares, R. .
ANNALS OF ONCOLOGY, 2008, 19 (09) :1619-1623
[8]   American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors [J].
Gilligan, Timothy D. ;
Seidenfeld, Jerome ;
Basch, Ethan M. ;
Einhorn, Lawrence H. ;
Fancher, Timothy ;
Smith, David C. ;
Stephenson, Andrew J. ;
Vaughn, David J. ;
Cosby, Roxanne ;
Hayes, Daniel F. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3388-3404
[9]   Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma [J].
Ha, Seung Cheol ;
Oh, Jungsu S. ;
Roh, Jong-Lyel ;
Moon, Hyojeong ;
Kim, Jae Seung ;
Cho, Kyung-Ja ;
Choi, Seung-Ho ;
Nam, Soon Yuhl ;
Kim, Sang Yoon .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (01) :33-40
[10]  
HAINSWORTH JD, 1992, SEMIN ONCOL, V19, P119